title: Roth spots in chronic myelogenous leukemia.
authors.affiliation: Department of Clinical Neurosciences, University of Calgary, Calgary, Alta. ronak.kapadia@albertahealthservices.ca
authors.forename: Ronak K
authors.initials: RK
authors.lastname: Kapadia
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Steeves
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001706:Biopsy; D001854:Bone Marrow Cells / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D010879:Piperazines / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use; D012160:Retina / Q000473:pathology*; D012166:Retinal Hemorrhage / Q000209:etiology / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases